HROW
Price
$28.72
Change
-$0.79 (-2.68%)
Updated
Jun 5 closing price
Capitalization
467.85M
67 days until earnings call
TLPH
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
17.48M
Interact to see
Advertisement

HROW vs TLPH

Header iconHROW vs TLPH Comparison
Open Charts HROW vs TLPHBanner chart's image
Harrow
Price$28.72
Change-$0.79 (-2.68%)
Volume$469.52K
Capitalization467.85M
Talphera
Price$0.49
Change-$0.00 (-0.00%)
Volume$17.35K
Capitalization17.48M
HROW vs TLPH Comparison Chart
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. TLPH commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Buy and TLPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (HROW: $28.72 vs. TLPH: $0.49)
Brand notoriety: HROW and TLPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 91% vs. TLPH: 43%
Market capitalization -- HROW: $467.85M vs. TLPH: $17.48M
HROW [@Pharmaceuticals: Other] is valued at $467.85M. TLPH’s [@Pharmaceuticals: Other] market capitalization is $17.48M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, HROW is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 6 TA indicator(s) are bullish while TLPH’s TA Score has 3 bullish TA indicator(s).

  • HROW’s TA Score: 6 bullish, 4 bearish.
  • TLPH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HROW is a better buy in the short-term than TLPH.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а +5.59% price change this week, while TLPH (@Pharmaceuticals: Other) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

HROW is expected to report earnings on Aug 12, 2025.

TLPH is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($468M) has a higher market cap than TLPH($17.5M). TLPH YTD gains are higher at: -6.964 vs. HROW (-14.396). HROW has higher annual earnings (EBITDA): 9.95M vs. TLPH (-9.84M). HROW has more cash in the bank: 82.8M vs. TLPH (9.38M). HROW has higher revenues than TLPH: HROW (130M) vs TLPH (651K).
HROWTLPHHROW / TLPH
Capitalization468M17.5M2,674%
EBITDA9.95M-9.84M-101%
Gain YTD-14.396-6.964207%
P/E Ratio39.53N/A-
Revenue130M651K19,969%
Total Cash82.8M9.38M883%
Total Debt191MN/A-
FUNDAMENTALS RATINGS
HROW vs TLPH: Fundamental Ratings
HROW
TLPH
OUTLOOK RATING
1..100
1351
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
52100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
4185
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (77) in the Pharmaceuticals Other industry is in the same range as TLPH (96). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.

HROW's Profit vs Risk Rating (52) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPH (100). This means that HROW’s stock grew somewhat faster than TLPH’s over the last 12 months.

HROW's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as TLPH (95). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.

HROW's Price Growth Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPH (85). This means that HROW’s stock grew somewhat faster than TLPH’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for TLPH (100). This means that HROW’s stock grew significantly faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWTLPH
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOSBX28.480.01
+0.04%
Tributary Small Company Instl Plus
ACFSX70.33N/A
N/A
American Century Focused Dynamic Gr I
VHGEX37.86N/A
N/A
Vanguard Global Equity Inv
HOOSX28.20N/A
N/A
Hartford Schroders US Small Cap Opps R4
RIERX12.80N/A
N/A
RBC International Equity R6

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-2.68%
AMRX - HROW
45%
Loosely correlated
-0.55%
EBS - HROW
37%
Loosely correlated
-4.42%
OGI - HROW
33%
Loosely correlated
-2.24%
VTRS - HROW
32%
Poorly correlated
-1.63%
TLRY - HROW
32%
Poorly correlated
-5.40%
More